Assessing an ophthalmic market opportunity
Challenge
A leading research institute developing novel approaches for the production of ophthalmic treatments wanted to conduct a market and competitive assessment of the current supplier base and prospective novel technological approaches.
Solution
Our consultants conducted the project in two parts:
- Assessing the market size, the structure and segmentation of related products (e.g. by application and geography) and demand growth rates. This was followed by structure characterization of the supply chains and identification of the current and developmental competing production technologies, or other technologies that could be applied to the production of relevant products. The findings from this part of the exercise allowed us to review the competitive positioning of the client’s technology.
- Assessing the competitive environment, applying Michael Porter’s Five Forces framework (modified to incorporate the impact of regulation which was an important factor in this particular industry) to illustrate the competitive landscape. Both parts of the project involved primary data collection, predominantly through selected telephone interviews, to supplement secondary data sources.
Related Case Studies
Explore similar engagements and see how we've helped other clients achieve their goals.
Strategy & Commercialization
Evaluating the Commercial Viability of a Novel Neonatal Therapy Approach
Challenge: A leading U.S. children’s hospital commissioned an independent review of a novel therapeutic approach for rare neonatal diseases. The principal investigator (PI) - a...
Strategy & Commercialization
Landscape Assessment of Novel Pain Targets for R&D Prioritization
Challenge: A privately held US-based biotech company specializing in pain therapeutics had developed a cutting-edge drug discovery platform utilizing multi-omic, tissue-specific...
Strategy & Commercialization
Axl/merTK target assessment for an AI-driven drug discovery company
Challenge: An AI-driven drug discovery company requested an expert third party assessment of the attractiveness and risks of a particular discovery strategy focused on a dual...
Strategy & Commercialization
Technical Feasibility Ranking of Gene Therapies for CNS Diseases
Challenge: A mid-sized pharmaceutical company was considering the option of expanding into developing gene therapies for CNS diseases. Alacrita was asked to help them evaluate and...
Interested in Learning More?
Contact us to discuss how we can support your project with similar expertise.